Literature DB >> 14066431

SPECIFIC VIRAL INTERFERENCE IN HELA CELL CULTURES CHRONICALLY INFECTED WITH COXSACKIE B5 VIRUS.

R L CROWELL.   

Abstract

Crowell, Richard L. (Hahnemann Medical College, Philadelphia, Pa.). Specific viral interference in HeLa cell cultures chronically infected with Coxsackie B5 virus. J. Bacteriol. 86:517-526. 1963.-The presence of large amounts of Coxsackie B5 virus in culture fluids of a HeLa subline, serially propagated over a 3-year period, provided evidence for attainment of a viral carrier state. Human serum in the growth medium of carrier cultures appeared prerequisite for maintenance of a stable virus-cell equilibrium. Virus was eliminated from HeLa cells by addition of B5 antiserum to the growth medium, whereas subcultivation in calf serum medium resulted in cellular degeneration by virus. HeLa cells, chronically infected by B5 virus, retained normal morphology in monolayer cultures and were found preservable by freezing. Persistently infected HeLa cells formed colonies with high efficiency in a medium containing B5 antiserum, to provide evidence that the majority of cells in carrier populations were not fatally infected. The significance of occurrence of small and large plaque variants of B5 virus in the carrier system remains to be determined. Coxsackie B5-carrier cultures were found specifically resistant to superinfection by all members of Coxsackie group B. This resistance, due to viral interference, was not extended to three immunological types of Coxsackie group A, poliovirus types 1 to 3, adenovirus T1, or vaccinia virus. Viral interference was found to be a consequence of altered surfaces of carrier cells, as reflected by decreased adsorption kinetics and cell penetration by Coxsackie group B viruses. The data suggested that Coxsackie group B viruses share a unique requirement, distinct from that of polioviruses, for reception and eclipse by HeLa cells. Interference between polioviruses and members of Coxsackie group B is discussed.

Entities:  

Keywords:  COXSACKIE VIRUSES; EXPERIMENTAL LAB STUDY; TISSUE CULTURE; VIRUS CULTIVATION

Mesh:

Year:  1963        PMID: 14066431      PMCID: PMC278466          DOI: 10.1128/jb.86.3.517-526.1963

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  20 in total

1.  Mixed viral infections: interactions between Coxsackie virus and poliovirus in mice and tissue cultures.

Authors:  S HALPERN; S E SULKIN
Journal:  Tex Rep Biol Med       Date:  1961

2.  Studies on antiviral immunity using tissue culture methods. II. Obtaining cells resistant to poliomyelitis virus.

Authors:  V D SOLOVYOV; N E GULEVICH
Journal:  Acta Virol       Date:  1960-07       Impact factor: 1.162

3.  Alteration plaque morphology of EMC virus with polycations.

Authors:  H LIEBHABER; K K TAKEMOTO
Journal:  Virology       Date:  1961-08       Impact factor: 3.616

4.  The basis for variation in susceptibility to poliovirus in HeLa cells.

Authors:  J E DARNELL; T K SAWYER
Journal:  Virology       Date:  1960-08       Impact factor: 3.616

5.  Virus-cell relationship in a carrier culture of HeLa cells and Coxsackie A9 virus.

Authors:  K K TAKEMOTO; K HABEL
Journal:  Virology       Date:  1959-01       Impact factor: 3.616

6.  Status of field trials with an orally administered, live attenuated poliovirus vaccine.

Authors:  A B SABIN
Journal:  J Am Med Assoc       Date:  1959-10-17

7.  Action of anticellular sera on virus infections. I. Influence on homologous tissue cultures infected with various viruses.

Authors:  L QUERSIN-THIRY
Journal:  J Immunol       Date:  1958-09       Impact factor: 5.422

8.  Mutation of polioviruses to resistance to neutralizing substances in normal bovine sera.

Authors:  N TAKEMORI; S NOMURA; M NAKANO; Y MORIOKA; M HENMI; M KITAOKA
Journal:  Virology       Date:  1958-02       Impact factor: 3.616

9.  The effect of anticellular sera on virus multiplication in tissue culture.

Authors:  K HABEL; J W HORNIBROOK; N C GREGG; R J SILVERBERG; K K TAKEMOTO
Journal:  Virology       Date:  1958-02       Impact factor: 3.616

10.  Poliovirus-carrying lines of HeLa cells: their establishment and sensitivity to viruses.

Authors:  S PACSA
Journal:  Acta Microbiol Acad Sci Hung       Date:  1961
View more
  15 in total

1.  EFFECT OF ENZYMES ON THE INTERACTION OF ENTEROVIRUSES WITH LIVING HELA CELLS.

Authors:  I ZAJAC; R L CROWELL
Journal:  J Bacteriol       Date:  1965-03       Impact factor: 3.490

Review 2.  Strategies for the identification of icosahedral virus receptors.

Authors:  D M Bass; H B Greenberg
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

3.  A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses.

Authors:  K H Hsu; K Lonberg-Holm; B Alstein; R L Crowell
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

4.  Characterization of a YAC-1 mouse cell receptor for group B coxsackieviruses.

Authors:  K H Hsu; R L Crowell
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

5.  Effect of anticellular serum on the attachment of enteroviruses to HeLa cells.

Authors:  D A Axler; R L Crowell
Journal:  J Virol       Date:  1968-08       Impact factor: 5.103

6.  Differential inhibition of attachment and eclipse activities of HeLa cells for enteroviruses.

Authors:  I Zajac; R L Crowell
Journal:  J Virol       Date:  1969-04       Impact factor: 5.103

7.  Specific cell-surface alteration by enteroviruses as reflected by viral-attachment interference.

Authors:  R L Crowell
Journal:  J Bacteriol       Date:  1966-01       Impact factor: 3.490

8.  Carrier cultures of human fetal diploid cells infected with coxsackievirus type B2.

Authors:  N H Maverakis; N J Schmidt; J L Riggs; E H Lennette
Journal:  Arch Gesamte Virusforsch       Date:  1973

9.  Rubella virus carrier cultures derived from congenitally infected infants.

Authors:  W E Rawls; J L Melnick
Journal:  J Exp Med       Date:  1966-05-01       Impact factor: 14.307

10.  Non-cytopathic infection of rhabdomyosarcoma cells by coxsackie B5 virus.

Authors:  E Argo; B Gimenez; P Cash
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.